Karl Doghramji, MD
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Professor, Psychiatry and Human Behavior
Associate Professor, Neurology

Contact Dr. Doghramji

211 S. Ninth Street, Suite 500
Philadelphia, PA 19107

(215) 955-6175
(215) 955-9783 (fax)

Medical School
Jefferson Medical College, Philadelphia, PA (1980)

Residency
Internship in Internal Medicine, Presbyterian-University of Pennsylvania Medical Center, Philadelphia, PA (1981)
Residency in Psychiatry, Thomas Jefferson University Hospital, Philadelphia, PA (1984)

Fellowship
Clinical Research Fellowship in Sleep Disorders Medicine and Polysomnography, Montefiore Medical Center, Albert Einstein Medical Center, Bronx, NY (1984)

Board Certification
American Board of Psychiatry and Neurology, Certified in Psychiatry
American Board of Sleep Medicine

University Appointment
Professor, Psychiatry and Human Behavior
Associate Professor, Neurology

Hospital Appointment
Medical Director, Jefferson Sleep Disorders Center

Research and Clinical Interests
Gastroesophageal reflux and sleep; identification and management of sleep apnea syndrome in the perioperative patient; novel medications for sleep disorders; surgical treatments for obstructive sleep apnea syndrome; comorbidity between ADHD and sleep apnea syndrome; Sleep disorders; sleep apnea syndrome; narcolepsy; insomnia; restless legs syndrome; circadian rhythm sleep disorders; parasomnias

Publications

1. Parasomnias, violence and the law
2. Epidemiology of insomnia
3. Excessive sleepiness: under-recognized and essential marker for sleep/wake disorder management.
4. Special supplement to current medical research & opinion: Excessive sleepiness: Under-recognized and essential marker for sleep/wake disorder management
5. Obstructive sleep apnea syndrome and postoperative complications: Clinical use of the STOP-BANG questionnaire
6. Chapter 5 The maintenance of wakefulness test
7. The evaluation and management of insomnia
8. Effect of Zolpidem on the Sleep Arousal Response to Nocturnal Esophageal Acid Exposure
9. Effect of Zolpidem on the Sleep Arousal Response to Nocturnal Esophageal Acid Exposure
10. Preface
11. Melatonin and its receptors: A new class of sleep-promoting agents
12. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness
13. The scoring of arousal in sleep: Reliability, validity, and alternatives
14. Preface
15. Medical causes of disturbed sleep in psychiatric patients
16. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening
17. The epidemiology and diagnosis of insomnia
18. Periodic restless legs syndrome associated with quetiapine use: A case report [6]
19. The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters
20. Derivation of research diagnostic criteria for insomnia: Report of an American Academy of Sleep Medicine work group

View All Publications